R. Michael van Dam

Available for Consulting

I am available for consulting in the areas of microfluidics, prototyping, automated systems, radiochemistry technology development and evaluation, PET tracer production, and new PET tracer development and evaluation.

Brief Biography

Dr. van Dam received his bachelor's degree in Engineering Physics from Queen's University (Kingston, ON, Canada), and then received his master's degree in Computer Engineering from the University of Toronto (Toronto, ON, Canada), where he worked under the direction of Prof. Zvonko G. Vranesic (Department of Electrical and Computer Engineering) on communication networks in multiprocessor systems (NUMAchine Multiprocessor Project). He obtained his doctoral degree in Applied Physics from the California Institute of Technology (Pasadena, CA, USA), where he worked under the direction of Prof. Stephen R. Quake (Department of Applied Physics; now at Department of Bioengineering, Stanford University) on developing chemically-resistant microfluidic devices for chemical synthesis applications. After graduate school, he worked under the direction of Prof. James R. Heath (Department of Chemistry, California Institute of Technology) on microfluidic devices for the synthesis of positron-emission tomography (PET) probes, and transitioned to a Senior Scientist role at Siemens Molecular Imaging Biomarker Research to commercialize this work. He joined the UCLA Department of Molecular & Medical Pharmacology in 2007. He is currently a Professor in the Crump Institute for Molecular Imaging, Department of Molecular & Medical Pharmacology, Department of Bioengineering, and the Physics and Biology in Medicine Graduate Program, as well as a Vice Chair of the Department of Molecular & Medical Pharmacology and a Co-Associate Director of the Crump Institute for Molecular Imaging. His research currently focuses on the development of novel, miniaturized technologies to perform multi-step radiosynthesis of radiopharmaceuticals (e.g. PET imaging tracers, theranostic agents) and high-sensitivity radiochemical analysis, and he is a pioneer in the development of high-throughput tools for radiochemical synthesis and analysis with applications in synthesis optimization and novel radiopharmaceutical development. He has published over 60 papers and multiple book chapters, and has been granted over 20 patents, related to these discoveries. Dr. van Dam is also a co-founder of Sofie, Inc., which has commercialized a flexible radiosynthesizer technology and intuitive unit-operation-based programming approach developed in his laboratory.

Curriculum Vitae

(Coming soon)

Contact:

R. Michael van Dam

Professor and Co-Associate Director

Crump Institute for Molecular Imaging

Department of Molecular & Medical Pharmacology

David Geffen School of Medicine at UCLA

California NanoSystems Institute, Room 4323

570 Westwood Plaza, Los Angeles, CA 90095

mvandam@mednet.ucla.edu

310-206-6507 (office)